ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,989.06
      -0.20%
      US Tech 100
      20,519.60
      -0.17%
      Dow Jones
      43,995.67
      -0.67%
      Brent Oil
      71.865
      0.06%
      Bitcoin
      89,764.97
      1.14%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Selecta Biosciences Inc (SELB)

      7. Selecta Biosciences Inc (SELB) Financials

      Selecta Biosciences Inc

      Selecta Biosciences Inc (SELB)

      NASDAQ
      0.8812
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Selecta Biosciences Inc Financial Summary

      The current SELB market cap is 136.77M. The company's latest EPS is USD -1.4156 and P/E is -11.91.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 5.25M6.55M8.27M5.84M33.45M
      Operating Income -18.64M-13.07M-36.33M-13.35M13.46M
      Net Income -11.39M-9M-177.66M-56.82M13.84M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6.68M16.6M85.08M110.78M26M
      Operating Income -52.46M-56.82M-4.6M14.54M-86.42M
      Net Income -55.35M-68.88M-25.69M35.38M-219.71M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 139.51M106.03M305.05M325.21M347.74M
      Total Liabilities 74.06M45.71M444.68M442.01M449.2M
      Total Equity 65.45M60.33M-440.18M-116.8M-101.46M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 99.57M165.44M159.88M165.89M305.05M
      Total Liabilities 91.17M183.44M137.36M72.06M444.68M
      Total Equity 8.4M-18.01M22.52M93.83M-440.18M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -18.66M-27.88M-51.16M-15.92M-30.36M
      Investing 28.11M28.11M34.61M-602k-2.19M
      Financing -2.44M-27.23M-13.15M43.03M43.15M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -51.44M34.88M-60.38M-31.63M-51.16M
      Investing 229k-741k-17.14M-15M34.61M
      Financing 105.04M14.43M52.9M39.22M-13.15M

      Stats and Ratios

      Market Cap 136.77M
      Price to Earnings Ratio -11.91
      Price to Sales Ratio 100.66
      Price to Cash Ratio 34.03
      Price to Book Ratio -18.74
      Dividend Yield -

      Share Statistics

      Shares Outstanding 155.2M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.03 (3.3%)

      Company Info

      Company Name Selecta Biosciences Inc
      Address corporation trust center
      wilmington, delaware 19801
      Website https://www.selectabio.com
      Industry pharmaceutical preparations (2834)